{"id":"NCT01787383","sponsor":"LEO Pharma","briefTitle":"A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities","officialTitle":"A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-02","primaryCompletion":"2014-01","completion":"2014-01","firstPosted":"2013-02-08","resultsPosted":"2015-05-07","lastUpdate":"2025-02-24"},"enrollment":200,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Actinic Keratosis"],"interventions":[{"type":"DRUG","name":"Ingenol mebutate gel 0.05 %","otherNames":["Picato®"]},{"type":"DRUG","name":"Ingenol mebutate gel 0.015 %","otherNames":["Picato®"]}],"arms":[{"label":"Ingenol mebutate gel 0.05 %","type":"ACTIVE_COMPARATOR"},{"label":"Ingenol mebutate gel 0.015 %","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this trial is to evaluate the safety of a simultaneous treatment regimen compared to a sequential treatment regimen when two separate areas with AKs (one located on face/scalp and the other located on trunk/ extremities) are treated with ingenol mebutate gel","primaryOutcome":{"measure":"Composite Local Skin Reaction (LSR) Score 3 Days After Treatment of Each Selected Treatment Area","timeFrame":"3 days after treatment of each selected treatment area","effectByArm":[{"arm":"Ingenol Mebutate Gel Simultaneous Treatment","deltaMin":10.4,"sd":5.1},{"arm":"Ingenol Mebutate Gel Sequential Treatment","deltaMin":9.7,"sd":4.5}],"pValues":[{"comp":"OG000 vs OG001","p":"0.13"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":19},"locations":{"siteCount":1,"countries":["Italy"]},"refs":{"pmids":["26300464"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":101},"commonTop":["Application site pruritus","Headache","Application site pain","Basal cell carcinoma","Squamous cell carcinoma of skin"]}}